{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:52:57Z","timestamp":1792273977992,"version":"4.4.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[1999,10,1]],"date-time":"1999-10-01T00:00:00Z","timestamp":938736000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[1999,10]]},"DOI":"10.1007\/bf03164869","type":"journal-article","created":{"date-parts":[[2009,9,26]],"date-time":"2009-09-26T06:12:09Z","timestamp":1253945529000},"page":"309-315","source":"Crossref","is-referenced-by-count":47,"title":["Preserved benzodiazepine receptors in Alzheimer\u2019s disease measured with C-11 flumazenil PET and I-123 iomazenil SPECT in comparison with CBF"],"prefix":"10.1007","volume":"13","author":[{"given":"Masashi","family":"Ohyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michio","family":"Senda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiichi","family":"Ishiwata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin","family":"Kitamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Mishina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hinako","family":"Toyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichi","family":"Oda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Katayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BF03164869_CR1","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1136\/jnnp.50.6.752","volume":"50","author":"RJ Polinsky","year":"1987","unstructured":"Polinsky RJ, Noble H, Di Chiro G, Nee LE, Feldman RG, Brown RT. Dominantly inherited Alzheimer\u2019s disease: cerebral glucose metabolism.J Neurol Neurosurg Psychiatry 50: 752\u2013757, 1987.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BF03164869_CR2","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1212\/WNL.33.8.961","volume":"33","author":"NL Foster","year":"1983","unstructured":"Foster NL, Chase TN, Fedio P, Patronas NJ, Brooks RA, Di Chiro G. Alzheimer\u2019s disease: focal cortical changes shown by positron emission tomography.Neurology 33: 961\u2013965, 1983.","journal-title":"Neurology"},{"key":"BF03164869_CR3","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/ana.410160605","volume":"16","author":"NL Foster","year":"1984","unstructured":"Foster NL, Chase TN, Mansi L, Brooks R, Fedio P, Patronas NJ, et al. Cortical abnormalities in Alzheimer\u2019s disease.Ann Neurol 16: 649\u2013654, 1984.","journal-title":"Ann Neurol"},{"key":"BF03164869_CR4","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/ana.410180305","volume":"18","author":"NR Cutler","year":"1985","unstructured":"Cutler NR, Haxby JV, Duara R, Grady CL, Kay AD, Kessler RM, et al. Clinical history, brain metabolism, and neuropsychological function in Alzheimer\u2019s disease.Ann Neurol 18: 298\u2013309, 1985.","journal-title":"Ann Neurol"},{"key":"BF03164869_CR5","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1212\/WNL.36.7.879","volume":"36","author":"R Duara","year":"1986","unstructured":"Duara R, Grady C, Haxby J, Sundaram M, Cutler NR, Heston L, et al. Positron emission tomography in Alzheimer\u2019s disease.Neurology 36: 879\u2013887, 1986.","journal-title":"Neurology"},{"key":"BF03164869_CR6","first-page":"1238","volume":"36","author":"S Minoshima","year":"1995","unstructured":"Minoshima S, Frey KA, Koeppe RA, Foster NL, Kuhl DE. A diagnostic approach in Alzheimer\u2019s disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET.J Nucl Med 36: 1238\u20131248, 1995.","journal-title":"J Nucl Med"},{"key":"BF03164869_CR7","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/ana.410420114","volume":"42","author":"S Minoshima","year":"1997","unstructured":"Minoshima S, Giordani B, Berent S, Frey KA, Foster NL, Kuhl DE. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer\u2019s disease.Ann Neurol 42: 85\u201394, 1997.","journal-title":"Ann Neurol"},{"key":"BF03164869_CR8","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1017\/S0317167100037227","volume":"13","author":"EG McGeer","year":"1986","unstructured":"McGeer EG, McGeer PL, Kamo H, Tago H, Harrop R. Cortical metabolism, acetylcholinesterase staining and pathological changes in Alzheimer\u2019s disease.Can J Neurol Sci 13: 511\u2013516, 1986.","journal-title":"Can J Neurol Sci"},{"key":"BF03164869_CR9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0317167100029930","volume":"17","author":"EG McGeer","year":"1990","unstructured":"McGeer EG, Peppard RP, McGeer PL, Tuokko H, Crockett D, Parks R, et al.18Fluorodeoxy glucose positron emission tomography studies in presumed Alzheimer cases, including 13 serial scans.Can J Neurol Sci 17: 1\u201311, 1990.","journal-title":"Can J Neurol Sci"},{"key":"BF03164869_CR10","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/0197-4580(92)90076-A","volume":"13","author":"JL Eberling","year":"1992","unstructured":"Eberling JL, Jagust WJ, Reed BR, Baker MG. Reduced temporal lobe blood flow in Alzheimer\u2019s disease.Neurobiol Aging 13: 483\u2013491, 1992.","journal-title":"Neurobiol Aging"},{"key":"BF03164869_CR11","first-page":"1171","volume":"30","author":"S Kitamura","year":"1990","unstructured":"Kitamura S, Araki T, Sakamoto S, Iio M, Terashi A. Cerebral blood flow and cerebral oxygen metabolism in patients with dementia of frontal lobe type.Jpn Clinical Neurology 30: 1171\u20131175, 1990.","journal-title":"Jpn Clinical Neurology"},{"key":"BF03164869_CR12","first-page":"293","volume":"39","author":"K Ishii","year":"1998","unstructured":"Ishii K, Sasaki M, Yamaji S, Sakamoto S, Kitagaki H, Mori E. Paradoxical hippocampus perfusion in mild-to-moderate Alzheimer\u2019s disease.J Nucl Med 39: 293\u2013298, 1998.","journal-title":"J Nucl Med"},{"key":"BF03164869_CR13","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/jcbfm.1995.34","volume":"15","author":"J Delforge","year":"1995","unstructured":"Delforge J, Pappata S, Millet P, Samson Y, Bendriem B, Jobert A, et al. Quantification of benzodiazepine receptors in human brain using PET, [11C]flumazenil, and a single-experiment protocol.J Cereb Blood Flow Metab 15: 284\u2013300, 1995.","journal-title":"J Cereb Blood Flow Metab"},{"key":"BF03164869_CR14","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/jcbfm.1991.130","volume":"11","author":"RA Koeppe","year":"1991","unstructured":"Koeppe RA, Holthoff VA, Frey KA, Kilbourn MR, Kuhl DE. Compartmental analysis of [11C]flumazenil kinetics for the estimation of ligand transport rate and receptor distribution using positron emission tomography.J Cereb Blood Flow Metab 11: 735\u2013744, 1991.","journal-title":"J Cereb Blood Flow Metab"},{"key":"BF03164869_CR15","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/BF03165418","volume":"12","author":"K Ishiwata","year":"1998","unstructured":"Ishiwata K, Takehito I, Ohyama M, Yamada T, Mishina M, Ishii K, et al. Metabolite analysis of [11C]flumazenil in human plasma: Assessment as the standardized value for quantitative PET studies.Ann Nucl Med 12: 55\u201359, 1998.","journal-title":"Ann Nucl Med"},{"key":"BF03164869_CR16","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/jcbfm.1991.131","volume":"11","author":"VA Holthoff","year":"1991","unstructured":"Holthoff VA, Koeppe RA, Frey KA, Paradise AH, Kuhl DE. Differentiation of radioligand delivery and binding in the brain: validation of a two-compartment model for [11C]flumazenil.J Cereb Blood Flow Metab 11: 745\u2013752, 1991.","journal-title":"J Cereb Blood Flow Metab"},{"key":"BF03164869_CR17","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1001\/archneur.1995.00540270110027","volume":"52","author":"M Meyer","year":"1995","unstructured":"Meyer M, Koeppe RA, Frey KA, Foster NL, Kuhl DE. Positron emission tomography measures of benzodiazepine binding in Alzheimer\u2019s disease.Arch Neurol 52: 314\u2013317, 1995.","journal-title":"Arch Neurol"},{"key":"BF03164869_CR18","first-page":"2154","volume":"36","author":"J Hatazawa","year":"1995","unstructured":"Hatazawa J, Satoh T, Shimosegawa E, Okudera T, Inugami A, Ogawa T, et al. Evaluation of cerebral infarction with iodine 123-iomazenil SPECT.J Nucl Med 36: 2154\u20132161, 1995.","journal-title":"J Nucl Med"},{"key":"BF03164869_CR19","first-page":"1007","volume":"31","author":"HF Beer","year":"1990","unstructured":"Beer HF, Blauenstein PA, Hasler PH, Delaloye B, Riccabona G, Bangerl I, et al.In vitro andin vivo evaluation of iodine-123-Ro 16-0154: a new imaging agent for SPECT investigations of benzodiazepine receptors.J Nucl Med 31: 1007\u20131014, 1990.","journal-title":"J Nucl Med"},{"key":"BF03164869_CR20","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0925-4927(92)90001-K","volume":"45","author":"SW Woods","year":"1992","unstructured":"Woods SW, Seibyl JP, Goddard AW, Dey HM, Zoghbi SS, Germine M, et al. Dynamic SPECT imaging after injection of the benzodiazepine receptor ligand [123I]iomazenil in healthy human subjects.Psychiatry Res 45: 67\u201377, 1992.","journal-title":"Psychiatry Res"},{"key":"BF03164869_CR21","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/0024-3205(90)90182-Q","volume":"47","author":"EW Johnson","year":"1990","unstructured":"Johnson EW, Woods SW, Zoghbi S, McBride BJ, Baldwin RM, Innis RB. Receptor binding characterization of the benzodiazepine radioligand125I-Ro 16-0154: potential probe for SPECT brain imaging.Life Sci 47: 1535\u20131546, 1990.","journal-title":"Life Sci"},{"key":"BF03164869_CR22","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0014-2999(91)90043-P","volume":"193","author":"R Innis","year":"1991","unstructured":"Innis R, Zoghbi S, Johnson E, Woods S, al-Tikriti M, Baldwin R, et al. SPECT imaging of the benzodiazepine receptor in non-human primate brain with [123I]Ro 16-0154.Eur J Pharmacol 193: 249\u2013252, 1991.","journal-title":"Eur J Pharmacol"},{"key":"BF03164869_CR23","first-page":"49","volume":"33","author":"S Kitamura","year":"1996","unstructured":"Kitamura S, Koshi Y, Komiyama T, Sakayori O, Komaba Y, Ohyama M, et al. Benzodiazepine receptor and cerebral blood flow in early Alzheimer\u2019s disease\u2014SPECT study using123I-iomazenil and123I-IMP.KAKU IGAKU (Jpn J Nucl Med) 33: 49\u201356, 1996.","journal-title":"KAKU IGAKU (Jpn J Nucl Med)"},{"key":"BF03164869_CR24","first-page":"61","volume":"4","author":"PD Griffiths","year":"1993","unstructured":"Griffiths PD, Crossman AR. Distribution of iron in the basal ganglia and neocortex in postmortem tissue in Parkinson\u2019s disease and Alzheimer\u2019s disease.Dementia 4: 61\u201365, 1993.","journal-title":"Dementia"},{"key":"BF03164869_CR25","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/ana.410230419","volume":"23","author":"S Shimohama","year":"1988","unstructured":"Shimohama S, Taniguchi T, Fujiwara M, Kameyama M. Changes in benzodiazepine receptors in Alzheimer-type dementia.Ann Neurol 23: 404\u2013406, 1988.","journal-title":"Ann Neurol"},{"key":"BF03164869_CR26","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1212\/WNL.37.9.1454","volume":"37","author":"DCM Chu","year":"1987","unstructured":"Chu DCM, Penney JBJ, Young AB. Cortical GABA b and GABAa receptors in Alzheimer\u2019s disease: a quantitative autoradiographic study.Neurology 37: 1454\u20131459, 1987.","journal-title":"Neurology"},{"key":"BF03164869_CR27","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0022-510X(84)90029-7","volume":"64","author":"A Cross","year":"1984","unstructured":"Cross A, Crow T, Johnson J, Perry E, Perry R, Blessed G, et al. Studies on neurotransmitter receptor systems in neocortex and hippocampus in senile dementia of the Alzheimer-type.J Neurol Sci 64: 109\u2013117, 1984.","journal-title":"J Neurol Sci"},{"key":"BF03164869_CR28","first-page":"467","volume":"38","author":"K Fukuchi","year":"1997","unstructured":"Fukuchi K, Hashikawa K, Seike Y, Moriwaki H, Oku N, Ishida M, et al. Comparison of iodine-123-iomazenil SPECT and technetium-99m-HMPAO-SPECT in Alzheimer\u2019s disease.J Nucl Med 38: 467\u2013470, 1997.","journal-title":"J Nucl Med"},{"key":"BF03164869_CR29","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1476-5381.1992.tb14466.x","volume":"107","author":"JA Miller","year":"1992","unstructured":"Miller JA, Dudley MW, Kehne JH, Sorensen SM, Kane JM. MDL 26,479: a potential cognition enhancer with benzodiazepine inverse agonist-like properties.Br J Pharmacol 107: 78\u201386, 1992.","journal-title":"Br J Pharmacol"},{"key":"BF03164869_CR30","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0166-2236(88)90042-2","volume":"11","author":"M Sarter","year":"1988","unstructured":"Sarter M, Schneider HH, Stephens DN. Treatment strategies for senile dementia: antagonist beta-carbolines.Trends in Neumsciences 11: 13\u201317, 1988.","journal-title":"Trends in Neumsciences"},{"key":"BF03164869_CR31","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/(SICI)1099-081X(199705)18:4<325::AID-BDD21>3.0.CO;2-1","volume":"18","author":"D Robbins","year":"1997","unstructured":"Robbins D, Hutcheson S, Miller T, Green V, Bhargava V, Weir S. Pharmacokinetics of MDL 26479, a novel benzodiazepine inverse agonist, in normal volunteers.Biopharm Drug Dispos 18: 325\u2013334, 1997.","journal-title":"Biopharm Drug Dispos"},{"key":"BF03164869_CR32","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0278-5846(96)00136-4","volume":"20","author":"K Kawasaki","year":"1996","unstructured":"Kawasaki K, Eigyo M, Ikeda M, Kihara T, Koike K, Matsushita A, et al. A novel benzodiazepine inverse agonist, S-8510, as a cognitive enhancer.Prog Neuropsycho-pharmacol Biol Psychiatry 20: 1413\u20131425, 1996.","journal-title":"Prog Neuropsycho-pharmacol Biol Psychiatry"},{"key":"BF03164869_CR33","first-page":"412","volume":"66","author":"P Bartenstein","year":"1995","unstructured":"Bartenstein P, Koepp M. Benzodiazepine receptor imaging with positron emission tomography and single photon emission tomography.Nervenarzt 66: 412\u2013421, 1995.","journal-title":"Nervenarzt"},{"key":"BF03164869_CR34","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","volume":"34","author":"G McKhann","year":"1984","unstructured":"McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease.Neurology 34: 939\u2013944, 1984.","journal-title":"Neurology"},{"key":"BF03164869_CR35","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR. Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician.J Psychiatr Res 12: 189\u2013198, 1975.","journal-title":"J Psychiatr Res"},{"key":"BF03164869_CR36","first-page":"653","volume":"24","author":"B Reisberg","year":"1988","unstructured":"Reisberg B. Functional assessment staging (FAST).Psychopharmacology Bulletin 24: 653\u2013659, 1988.","journal-title":"Psychopharmacology Bulletin"},{"key":"BF03164869_CR37","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1109\/23.34594","volume":"NS-37","author":"H Iida","year":"1989","unstructured":"Iida H, Miura S, Kanno I, Murakami M, Yamamoto S, Amano M. Design and evaluation of Headtome-IV, a wholebody positron emission tomography.IEEE Trans Nucl Sci NS-37: 1006\u20131010, 1989.","journal-title":"IEEE Trans Nucl Sci"},{"key":"BF03164869_CR38","first-page":"782","volume":"24","author":"P Herscovitch","year":"1983","unstructured":"Herscovitch P, Markham J, Raichle ME. Brain blood flow measured with intravenous H2 15O: I. Theory and error analysis.J Nucl Med 24: 782\u2013789, 1983.","journal-title":"J Nucl Med"},{"key":"BF03164869_CR39","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/00004647-199605000-00007","volume":"16","author":"KA Frey","year":"1996","unstructured":"Frey KA, Minoshima S, Koeppe RA, Kilbourn MR, Berger KL, Kuhl DE. Stereotaxic summation analysis of human cerebral benzodiazepine binding maps.J Cereb Blood Flow Metab 16: 409\u2013417, 1996.","journal-title":"J Cereb Blood Flow Metab"},{"key":"BF03164869_CR40","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1007\/BF01254474","volume":"23","author":"Y Onishi","year":"1996","unstructured":"Onishi Y, Yonekura Y, Tanaka F, Nishizawa S, Okazawa H, Ishizu K, et al. Delayed image of iodine-123 iomazenil as a relative map of benzodiazepine receptor binding: the optimal scan time.Eur J Nucl Med 23: 1491\u20131497, 1996.","journal-title":"Eur J Nucl Med"},{"key":"BF03164869_CR41","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/BF03164998","volume":"8","author":"M Senda","year":"1994","unstructured":"Senda M, Kanno I, Yonekura Y, Fujita H, Ishii K, Lyshkow H, et al. Comparison of anatomical standardization methods regarding the sensorimotor foci localization and between-subject variation in H2 15O PET activation, a three-center collaboration study.Ann Nucl Med 8: 201\u2013207, 1994.","journal-title":"Ann Nucl Med"},{"key":"BF03164869_CR42","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1007\/BF01367587","volume":"23","author":"A Soricelli","year":"1996","unstructured":"Soricelli A, Postiglione A, Grivet-Fojaja MR, Mainenti PP, Discepolo A, Varrone A, et al. Reduced cortical distribution volume of iodine-123 iomazenil in Alzheimer\u2019s disease as a measure of loss of synapses.Eur J Nucl Med 23: 1323\u20131328, 1996.","journal-title":"Eur J Nucl Med"},{"key":"BF03164869_CR43","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/00002093-199803000-00002","volume":"12","author":"J Fastbom","year":"1998","unstructured":"Fastbom J, Forsell Y, Winblad B. Benzodiazepines may have protective effects against Alzheimer disease.Alzheimer Dis Assoc Disord 12: 14\u201317, 1998.","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"BF03164869_CR44","first-page":"1462","volume":"36","author":"P Millet","year":"1995","unstructured":"Millet P, Delforge J, Mauguiere F, Pappata S, Cinotti L, Frouin V, et al. Parameter and index images of benzodiaz-epine receptor concentration in the brain.J Nucl Med 36: 1462\u20131471, 1995.","journal-title":"J Nucl Med"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03164869.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03164869\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03164869","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T22:52:06Z","timestamp":1558479126000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03164869"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,10]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1999,10]]}},"alternative-id":["BF03164869"],"URL":"https:\/\/doi.org\/10.1007\/bf03164869","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,10]]}}}